1. Effect of a phosphodiesterase type 3 inhibitor in oocyte maturation medium on subsequent mouse embryo development 
Byung Chul Jee, M.D., Hai-Ying Chen, B.Sc., Ri-Cheng Chian, Ph.D. 
Fertility and Sterility 
Volume 91, Issue 5, Pages (May 2009)
DOI: /j.fertnstert
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
A schematic diagram of the study. Three doses of cilostamide (1 μmol/L, 5 μmol/L, and 10 μmol/L) were used for prematuration cultures. PMSG = pregnant mare serum gonadotropin; CEO = cumulus-enclosed oocyte; GV = germinal vesicle–stage oocyte; MII = metaphase II oocyte.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Meiotic inhibition efficiencies after prematuration culture (PMC) for 24 hours by cilostamide in mouse cumulus-enclosed oocytes (CEOs). The arrest efficiencies were 86.7%, 100%, and 100% after 24 hours PMC, after treatment with cilostamide at concentrations of 1 μmol/L, 5 μmol/L, and 10 μmol/L, respectively (P=.037). GV = germinal vesicle–stage oocyte.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions